Société Cerulean Pharma Inc Nasdaq
Actions
US15708Q1058
Recherche biotechnologique et médicale
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Women's Health
100,0
%
| 10 | 100,0 % | 3 | 100,0 % | -71,92% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 3 | 100,0 % | -71,92% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 01/01/15 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/22 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/22 |
Christine Mauck
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/16 |
David Friend
CTO | Chief Tech/Sci/R&D Officer | - | 06/06/18 |
Mark Walters
COO | Chief Operating Officer | 69 | 01/01/15 |
Comptroller/Controller/Auditor | 47 | 01/10/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 01/01/15 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 20/11/19 |
Chairman | 75 | 01/01/14 | |
Sabrina Johnson
FOU | Founder | 57 | 01/01/15 |
Jessica Grossman
BRD | Director/Board Member | 52 | 09/04/18 |
Susan Kelley
BRD | Director/Board Member | 69 | 01/10/14 |
Gregory Matz
BRD | Director/Board Member | 64 | 13/09/18 |
Director/Board Member | 40 | 16/04/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 100 581 900 | 98 919 352 ( 98,35 %) | 0 | 98,35 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+21,74% | 46,4 Md | |
-0,97% | 41,75 Md | |
+47,07% | 41,37 Md | |
-3,52% | 29,71 Md | |
+11,12% | 26,01 Md | |
-19,37% | 19,52 Md | |
+31,18% | 12,43 Md | |
-0,04% | 12,13 Md | |
+0,39% | 12,18 Md |